The Role of Public Sector Agencies in Contraceptive Research and Development
Until recently, contraceptive product development, the translation of a research finding into a final product, was successfully carried out by profit-making, commercial pharmaceutical companies. Interaction between commercial companies, scientists, and drug-regulatory agencies has defined the steps necessary for development of a safe, acceptable, and economically feasible product. Expected financial returns from sales of the final product have driven the development process.
KeywordsContraceptive Method Family Planning Program Donor Agency Population Council Consumer Advocate
Unable to display preview. Download preview PDF.
- 1.Editorial (1980) Key findings highlight diversity. People 7:5Google Scholar
- 3.Wahren C (1984) The role of industry, agencies and governments in research on fertility regulation: past experience and future prospects. In: Diczfalusy A, Diczfalusy E (eds) Research on the regulation of human fertility. Scriptor, CopenhagenGoogle Scholar
- 4.UN General Assembly (1981) The least developed countries in the 1980s. UN conference on the least developed countries, A/CONF. 104/4 Add.lGoogle Scholar
- 5.UNFPA (1981) Family planning in the 1980s: challenges and opportunities. Report of the International Conference on Family Planning in the 1980s, Jakarta. New York: Population Council, New YorkGoogle Scholar
- 6.Buckles RG (1979) Contraceptive product development in public-sector programmes. PIACT paper 3Google Scholar
- 8.PIACT. NORPLANT® (1981) Instructions for cliniciansGoogle Scholar
- 11.Enever RP, Lewis GA (1983) The influence of pharmaceutical formulation upon biological activity of esters of norethisterone. Steroids 41:359Google Scholar